#cell therapy — Sunday, September 06, 2026 (1 items)
| 0 | ℹ |
PRMT7 restricts CD8+ T cells expansion via the NF-KappaB pathway.
(nature.com)
|
Nature Communications 2026-09-06 | #immunotherapy #cd8 t cells #cancer #cell therapy #signal transduction |